BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 25596540)

  • 1. New therapeutic options for advanced non-resectable malignant melanoma.
    Stadler S; Weina K; Gebhardt C; Utikal J
    Adv Med Sci; 2015 Mar; 60(1):83-8. PubMed ID: 25596540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy for advanced melanoma: fulfilling the promise.
    Gogas H; Polyzos A; Kirkwood J
    Cancer Treat Rev; 2013 Dec; 39(8):879-85. PubMed ID: 23725878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrating first-line treatment options into clinical practice: what's new in advanced melanoma?
    Dummer R; Schadendorf D; Ascierto PA; Larkin J; Lebbé C; Hauschild A
    Melanoma Res; 2015 Dec; 25(6):461-9. PubMed ID: 26426764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous melanoma.
    Eggermont AM; Spatz A; Robert C
    Lancet; 2014 Mar; 383(9919):816-27. PubMed ID: 24054424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted agents and immunotherapies: optimizing outcomes in melanoma.
    Luke JJ; Flaherty KT; Ribas A; Long GV
    Nat Rev Clin Oncol; 2017 Aug; 14(8):463-482. PubMed ID: 28374786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New developments in the treatment of metastatic melanoma: immune checkpoint inhibitors and targeted therapies.
    Azijli K; Stelloo E; Peters GJ; VAN DEN Eertwegh AJ
    Anticancer Res; 2014 Apr; 34(4):1493-505. PubMed ID: 24692676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New drug targets in metastatic melanoma.
    Homet B; Ribas A
    J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapeutic options in systemic treatment of advanced cutaneous melanoma.
    Mackiewicz-Wysocka M; Zolnierek J; Wysocki PJ
    Expert Opin Investig Drugs; 2013 Feb; 22(2):181-90. PubMed ID: 23215674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What's new in skin cancers?].
    Jouary T
    Ann Dermatol Venereol; 2014 Dec; 141 Suppl 4():S630-42. PubMed ID: 25539755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma in the brain: biology and therapeutic options.
    Gibney GT; Forsyth PA; Sondak VK
    Melanoma Res; 2012 Jun; 22(3):177-83. PubMed ID: 22495668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Status of Biological Therapies for the Treatment of Metastatic Melanoma.
    Tang T; Eldabaje R; Yang L
    Anticancer Res; 2016 Jul; 36(7):3229-41. PubMed ID: 27354579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Overview of the Changing Landscape of Treatment for Advanced Melanoma.
    Lee CS; Thomas CM; Ng KE
    Pharmacotherapy; 2017 Mar; 37(3):319-333. PubMed ID: 28052356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emerging Therapeutic Landscape of Advanced Melanoma.
    Henriques V; Martins T; Link W; Ferreira BI
    Curr Pharm Des; 2018; 24(5):549-558. PubMed ID: 29366407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gaining momentum: New options and opportunities for the treatment of advanced melanoma.
    Michielin O; Hoeller C
    Cancer Treat Rev; 2015 Sep; 41(8):660-70. PubMed ID: 26096079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel therapeutics for the treatment of metastatic melanoma.
    Mansfield AS; Markovic SN
    Future Oncol; 2009 May; 5(4):543-57. PubMed ID: 19450181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melanoma treatment update.
    Tsao H; Sober AJ
    Dermatol Clin; 2005 Apr; 23(2):323-33. PubMed ID: 15837158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy efficacy after first-line immunotherapy in 18 advanced melanoma patients.
    Saint-Jean M; Fronteau C; Peuvrel L; Khammari A; Varey E; Quéreux G; Dréno B
    Medicine (Baltimore); 2020 Jul; 99(29):e21329. PubMed ID: 32702928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New therapeutical strategies in the treatment of metastatic disease.
    Julia F; Thomas L; Dalle S
    Dermatol Ther; 2012; 25(5):452-7. PubMed ID: 23046024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment algorithms in stage IV melanoma.
    Espinosa E; Grob JJ; Dummer R; Rutkowski P; Robert C; Gogas H; Kefford R; Eggermont AM; Martin Algarra S; Hauschild A; Schadendorf D
    Am J Ther; 2015; 22(1):61-7. PubMed ID: 24413374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs in melanoma: it's a whole new world.
    Eggermont AM; Robert C
    Eur J Cancer; 2011 Sep; 47(14):2150-7. PubMed ID: 21802280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.